SCI's 8th Annual Capital Relief Trades Seminar

20 October 2022, London (In-Person Event)

One Bishops Square, London
E1 6AD

20 October 2022

25+ Speakers

Leading figures in the CRT Sector

250 Seats

Register to secure yours today


We are excited to announce the 8th Annual Capital Relief Trades Seminar will take place on 20th October 2022. We will return to London with Covid safety measures in place and featuring the same informative and engaging content you’ve grown to expect from SCI, we hope you will join us this October for another must attend event.


A number of regulatory items remain on the agenda for the SRT market, including a consultation on the STS synthetics framework and the implementation of RTS for the commensurate risk transfer test. SCI’s Capital Relief Trades Seminar will explore the impact of these developments, as well as the latest trends and activity across the sector.

Registration is now open

Cost per Delegate:

Non Subscriber Subscriber Rate
Super Early Bird – April – May £1,190 £1,050
Early Bird – June – July £1,260£1,120
Full Price – August – October £1,400 £1,190

To get your subscriber rate please contact for your discount code.

Exclusive Host

Gold Sponsors

Silver Sponsor



  • 27 April 2022
    An overview of issuance trends and activity in the capital relief trades market. What impact has the introduction of STS synthetics had on the sector?
    Panel Includes:
    Molly Whitehouse, ArrowMark Partners
    A focus on the latest regulatory developments impacting the capital relief trades market. How are banks demonstrating commensurate risk transfer in practice?
    A look at the latest structuring and documentation developments in the CRT market. How are issuers approaching aspects such as excess spread?
    An examination of the role of insurers in the CRT market
    Panel Includes:
    Oscar Holloway, Marsh
    Tom Russell, Liberty Specialty Markets
    An exploration of issuer perspectives on the CRT market. Are new issuers – in particular, standardised banks – entering the market? Which barriers to entry remain and what are the potential solutions?
    An examination of investor perspectives on the CRT market. How are investors approaching specialised lending and Stage Two asset portfolios?
    Panel Includes:
    Kaelyn Abrell, ArrowMark Partners
    An overview of the latest jurisdictions and asset classes to emerge on the CRT scene. What are the prospects for further issuance from Greece, Central and Eastern Europe, and Asia?